Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment (STLDD-1)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01380262
First received: June 22, 2011
Last updated: June 24, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)